LEPR and obesity due to melanocortin 4 receptor deficiency: Considering that the activation of LepR in hypothalamic neurons reduces food intake and may increase energy expenditure and fat oxidation [2,7], leptin sensitizing therapies will likely produce robust beneficial effects in the prevention and treatment of obesity [6,7,26].